With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
In January 2013, another class-action lawsuit was filed against Pfizer regarding its marketing of Zoloft. This time, the allegation is that the drug label and marketing materials do not mention the numerous clinical trials in which Zoloft was shown to be no more effective in treating depression than placebo. Instead, Pfizer’s consumers are given the impression that Zoloft is very effective for treating depression. (Plumlee v. Pfizer, Inc., Case No. 13-cv-00414, N.D. Cal.)
TINA.org and other consumer advocates file comment with FTC.
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Marketing and reality are not in sync.
New study opens the floodgates to class-action litigation.
Agency alleges MLM misled recruits about earnings, pressured distributors to buy products and encouraged fake retail sales.